IRIDEX Corporation (NASDAQ:IRIX) Stock Short Interest Falls 48.3%

IRIDEX Corporation (NASDAQ:IRIX – Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 39,421 shares, a drop of 48.3% from the October 15th total of 76,195 shares. Based on an average trading volume of 24,978 shares, the days-to-cover ratio is presently 1.6 days. Currently, 0.2% of the shares of the stock are sold short.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of IRIDEX from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, November 3rd. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $3.00.

Get Our Latest Report on IRIX

Institutional Trading of IRIDEX

Large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC raised its holdings in shares of IRIDEX by 6.7% during the 1st quarter. Renaissance Technologies LLC now owns 396,627 shares of the medical equipment provider’s stock worth $401,000 after acquiring an additional 25,067 shares during the period. Bank of New York Mellon Corp acquired a new position in shares of IRIDEX during the 2nd quarter valued at about $29,000. Diversify Wealth Management LLC purchased a new stake in shares of IRIDEX in the first quarter valued at about $35,000. Diversify Advisory Services LLC purchased a new stake in shares of IRIDEX in the second quarter valued at about $30,000. Finally, United Capital Financial Advisors LLC purchased a new stake in shares of IRIDEX in the second quarter valued at about $41,000. 20.10% of the stock is currently owned by hedge funds and other institutional investors.

IRIDEX Trading Down 0.3%

Shares of IRIDEX stock traded down $0.00 on Monday, hitting $0.69. 84,563 shares of the company were exchanged, compared to its average volume of 27,970. The company has a 50-day moving average price of $0.71 and a 200 day moving average price of $1.00. IRIDEX has a 1-year low of $0.61 and a 1-year high of $1.65.

IRIDEX (NASDAQ:IRIX – Get Free Report) last posted its quarterly earnings results on Tuesday, August 18th. The medical equipment provider reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.06). The firm had revenue of $12.57 million during the quarter, compared to analyst estimates of $13.59 million. Analysts predict that IRIDEX will post -0.12 EPS for the current fiscal year.

IRIDEX Company Profile

(Get Free Report)

IRIDEX Corporation develops, manufactures and markets laser-based medical systems and related delivery devices for eye-care professionals. Its products are used to treat retinal diseases and glaucoma, including through laser procedures designed to preserve or improve vision. The company’s offerings include ophthalmic laser systems such as the Cyclo G6 glaucoma laser system and IQ-series photocoagulators, along with treatment-delivery devices and technologies including MicroPulse laser therapy. IRIDEX was founded in 1989 and serves customers internationally through direct sales and distribution partners.

See Also

Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.